INNOVATIVE PHARMA PARTNER
InactiveINNOVATIVE PHARMA PARTNER was declared bankrupt on 06-09-2021 (Ondernemingsrechtbank Gent, afdeling Dendermonde). The bankruptcy was closed by liquidation by judgment of 30-09-2024, published in the Belgian Official Gazette on 04-10-2024.
Summary
Inactive. The last annual accounts are for financial year 2019.
Overview
Official details
Source: KBO- Status
- Inactive bankruptcy closed on 30-09-2024
- Activity
- No activity registered in the KBO
- Financial year end
- 30 June
- Peppol
- Not found in the Peppol Directory
Financial position
No score
Annual accounts to 30-06-2019
- Gross margin
- -€128,679
- Loss
- €2.3m
- Equity
- -€1.6m
- Total assets
- €119,461
- Staff
- 1 FTE
Turnover not published (abbreviated format)
Filed on 23-11-2020
Recent changes
- · Bankruptcy Bankruptcy closure (by liquidation)Enterprise Court of Ghent, Dendermonde division · judgment of 30-09-2024
- · Bankruptcy Bankruptcy declaredEnterprise Court of Ghent, Dendermonde division · judgment of 06-09-2021
Key facts about INNOVATIVE PHARMA PARTNER
- What is the company number of INNOVATIVE PHARMA PARTNER?
- The company number of INNOVATIVE PHARMA PARTNER is 0426.804.354. The VAT number is the same number with BE in front: BE 0426.804.354.
- What is the legal form of INNOVATIVE PHARMA PARTNER?
- The legal form of INNOVATIVE PHARMA PARTNER is BVBA.
- Is INNOVATIVE PHARMA PARTNER still active?
- No. INNOVATIVE PHARMA PARTNER is inactive in the KBO register.Company details
- How many employees did INNOVATIVE PHARMA PARTNER have?
- INNOVATIVE PHARMA PARTNER had an average of 1 full-time equivalents in financial year 2019, according to the filed annual accounts.Financials
- What is the turnover of INNOVATIVE PHARMA PARTNER?
- The annual accounts for financial year 2019 state no turnover. The abbreviated format does not require it.
- Is INNOVATIVE PHARMA PARTNER profitable?
- In financial year 2019, INNOVATIVE PHARMA PARTNER made a loss of €2.3m.
- Where can I find the annual accounts of INNOVATIVE PHARMA PARTNER?
- INNOVATIVE PHARMA PARTNER filed 35 annual accounts with the National Bank of Belgium, the latest for financial year 2019.